Prior JL - Search Results

1

Loss of the Par-1b/MARK2 polarity kinase leads to increased metabolic rate, decreased adiposity, and insulin hypersensitivity in vivo.

Hurov JB, Huang M, White LS, Lennerz J, Choi CS, Cho YR, Kim HJ, Prior JL, Piwnica-Worms D, Cantley LC, Kim JK, Shulman GI, Piwnica-Worms H. Hurov JB, et al. Among authors: prior jl. Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5680-5. doi: 10.1073/pnas.0701179104. Epub 2007 Mar 19. Proc Natl Acad Sci U S A. 2007. PMID: 17372192 Free PMC article.

2

Evidence for a plasma membrane-mediated permeability barrier to Tat basic domain in well-differentiated epithelial cells: lack of correlation with heparan sulfate.

Violini S, Sharma V, Prior JL, Dyszlewski M, Piwnica-Worms D. Violini S, et al. Among authors: prior jl. Biochemistry. 2002 Oct 22;41(42):12652-61. doi: 10.1021/bi026097e. Biochemistry. 2002. PMID: 12379107

3

Noninvasive bioluminescence imaging of herpes simplex virus type 1 infection and therapy in living mice.

Luker GD, Bardill JP, Prior JL, Pica CM, Piwnica-Worms D, Leib DA. Luker GD, et al. Among authors: prior jl. J Virol. 2002 Dec;76(23):12149-61. doi: 10.1128/jvi.76.23.12149-12161.2002. J Virol. 2002. PMID: 12414955 Free PMC article.

4

Characterization of novel histidine-tagged Tat-peptide complexes dual-labeled with (99m)Tc-tricarbonyl and fluorescein for scintigraphy and fluorescence microscopy.

Bullok KE, Dyszlewski M, Prior JL, Pica CM, Sharma V, Piwnica-Worms D. Bullok KE, et al. Among authors: prior jl. Bioconjug Chem. 2002 Nov-Dec;13(6):1226-37. doi: 10.1021/bc025573a. Bioconjug Chem. 2002. PMID: 12440857

5

Quantitative analysis of permeation peptide complexes labeled with Technetium-99m: chiral and sequence-specific effects on net cell uptake.

Gammon ST, Villalobos VM, Prior JL, Sharma V, Piwnica-Worms D. Gammon ST, et al. Among authors: prior jl. Bioconjug Chem. 2003 Mar-Apr;14(2):368-76. doi: 10.1021/bc0256291. Bioconjug Chem. 2003. PMID: 12643747

6

Molecular imaging of protein-protein interactions: controlled expression of p53 and large T-antigen fusion proteins in vivo.

Luker GD, Sharma V, Pica CM, Prior JL, Li W, Piwnica-Worms D. Luker GD, et al. Among authors: prior jl. Cancer Res. 2003 Apr 15;63(8):1780-8. Cancer Res. 2003. PMID: 12702563

7

Imaging reversal of multidrug resistance in living mice with bioluminescence: MDR1 P-glycoprotein transports coelenterazine.

Pichler A, Prior JL, Piwnica-Worms D. Pichler A, et al. Among authors: prior jl. Proc Natl Acad Sci U S A. 2004 Feb 10;101(6):1702-7. doi: 10.1073/pnas.0304326101. Epub 2004 Jan 30. Proc Natl Acad Sci U S A. 2004. PMID: 14755051 Free PMC article.

8

Kinetics of in vivo elimination of suicide gene-expressing T cells affects engraftment, graft-versus-host disease, and graft-versus-leukemia after allogeneic bone marrow transplantation.

Rettig MP, Ritchey JK, Prior JL, Haug JS, Piwnica-Worms D, DiPersio JF. Rettig MP, et al. Among authors: prior jl. J Immunol. 2004 Sep 15;173(6):3620-30. doi: 10.4049/jimmunol.173.6.3620. J Immunol. 2004. PMID: 15356106

9

CXCR4 regulates growth of both primary and metastatic breast cancer.

Smith MC, Luker KE, Garbow JR, Prior JL, Jackson E, Piwnica-Worms D, Luker GD. Smith MC, et al. Among authors: prior jl. Cancer Res. 2004 Dec 1;64(23):8604-12. doi: 10.1158/0008-5472.CAN-04-1844. Cancer Res. 2004. PMID: 15574767

10

Characterization of a 67Ga/68Ga radiopharmaceutical for SPECT and PET of MDR1 P-glycoprotein transport activity in vivo: validation in multidrug-resistant tumors and at the blood-brain barrier.

Sharma V, Prior JL, Belinsky MG, Kruh GD, Piwnica-Worms D. Sharma V, et al. Among authors: prior jl. J Nucl Med. 2005 Feb;46(2):354-64. J Nucl Med. 2005. PMID: 15695797 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page